Filing Flows › DexCom (DXCM) › Free cash flow
DexCom (DXCM) free cash flow by quarter
DexCom's free cash flow was $273M in Q3 2026 (third quarter 2026), +48% from Q2 2026. Over the last 7 quarters it ranged from $96.8M (Q1 2025) to $579M (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $273M | +48% | -53% |
| Q2 2026 | $184M | -59% | -12% |
| Q1 2026 | $449M | +134% | +364% |
| Q4 2025 | $192M | -67% | — |
| Q3 2025 | $579M | +177% | — |
| Q2 2025 | $209M | +116% | — |
| Q1 2025 | $96.8M | — | — |
Q3 2026 at a glance
DexCom, Q3 2026: revenue $1.3B (+11% year over year), operating margin 24.3%, net earnings $275M, operating cash flow $326M. The chart follows the revenue to costs, profit and cash.
Questions
What is DexCom's free cash flow?
DexCom's free cash flow was $273M in Q3 2026 (third quarter 2026), +48% from Q2 2026.
How has DexCom's free cash flow changed?
Over the last 7 quarters it ranged from $96.8M (Q1 2025) to $579M (Q3 2025).